Sarfez Pharmaceuticals, Inc.

Vienna, Virginia 22182

1 studies enrolling now · 1 studies all time

What they study most

Hypertension (HTN)

Studies at this site

• A Study Comparing the Clinical Benefit of Finerenone Versus a Fixed Dose Combination (FDC) of Extended-Release Torsemide and Spironolactone in Patients With Hypertension and Chronic Kidney Disease — Recruiting now